Feb 8- Breast implant maker Sientra Inc said it will resume selling all of its medical devices in the U.S. market from March 1, four months after it suspended sales of its breast implant devices to ensure technical compliance. The company had put a hold on sales of its implants in October, citing some technical compliance issues at Brazilian contract manufacturer...» Read More
*Buying Creganna from investment firm Permira for $895 mln. Feb 2- TE Connectivity Ltd, a Swiss-based manufacturer of electronics and sensors, said it would buy Creganna Medical Group for $895 million, expanding in the fast-growing business of making equipment used in minimally invasive procedures. "We expect our interventional sales post Creganna will...
Feb 2- Swiss-based communication equipment maker TE Connectivity Ltd said it would buy medical device maker Creganna Medical Group for $895 million, expanding in the fast-growing business of supplying equipment for minimally invasive procedures. TE bought another catheter systems maker, AdvancedCath, for $190 million in February 2015.
Feb 2- Communication equipment maker TE Connectivity Ltd said it would buy Ireland- based medical device maker Creganna Medical group for $895 million in cash.
One of the Fortune 500 company's biggest purchases comes as hospitals are under pressure to implement better in-house safety programs.
Feb 1- Medical device maker Stryker Corp said it would buy Sage Products LLC, which makes products used in intensive care units, from private equity firm Madison Dearborn Partners for $2.78 billion. The Kalamazoo, Michigan- based device maker also raised its 2016 adjusted earnings forecast by 5 cents to $5.55 -5.75 per share. J.P. Morgan Securities LLC is the...
Feb 1- Medical device maker Stryker Corp said it would buy Sage Products LLC, which makes products used in intensive care units, from private equity firm Madison Dearborn Partners for $2.78 billion.
*Sees 2016 adj profit $3.95- $4.05/ shr vs est $4.14. Q4 adj profit $1.02 vs est of $1.01. The company also said it expects 2016 adjusted profit of $3.95 to $4.05 per share, below the average analyst estimate of $4.14 per share.
Jan 27- Medical device maker St. Jude Medical Inc's quarterly profit more than halved as sales in its cardiac rhythm management business continued to fall. For the fourth quarter ended Jan.2, earnings attributable to the company fell to $113 million, or 39 cents per share, from $245 million, or 84 cents per share a year earlier.
U.S. health inspectors found problems at Theranos' northern California laboratory.
In an interview with CNBC, the NIH director said people may be "a little cynical" because of cancer's casualty rate, but researchers 'had its number.'
St Jude Medical Inc said the FDA has issued a Class I recall on faulty parts of its devices implanted into patients to control irregular heartbeats.
The company said on Tuesday that it expected to record pre-tax restructuring charges of $2.0 billion to $2.4 billion in connection with these plans, of which about $600 million will be recorded in the fourth quarter of 2015.. The restructuring is expected to result in annualized pre-tax cost savings of $800 million to $1 billion, J&J said.
In connection with its plans, J&J said it expected to record pre-tax restructuring charges of $2 billion to $2.4 billion, of which about $600 million will be recorded in the fourth quarter of 2015..
Jan 15- The U.S. Food and Drug Administration on Friday issued draft guidelines to medical device makers on how to protect patients from cybersecurity vulnerabilities in their devices. Joshua Corman, founder of I Am The Cavalry, a cybersafety advocacy group who worked with the FDA on the guidance, said he was extremely encouraged by the agency's action.
Jan 15- The U.S. Food and Drug Administration on Friday issued draft guidelines to medical device makers on how to protect patients from cybersecurity vulnerabilities in the devices. "Cybersecurity threats to medical devices are a growing concern," the agency said in a statement. "The exploitation of cybersecurity vulnerabilities presents a potential risk to...
Jan 11- Medical device maker Medtronic Plc said it planned to buy back shares worth up to $5 billion over the next couple of years. The company said on Monday an internal reorganization in September had resulted in cash and cash equivalents of $9.3 billion, which would be used to fund the buyback and to repay debt. Medtronic also raised the lower end of its full-year...
Mount Sinai Hospital's CEO told CNBC that while Obamacare survived a repeal attempt, it's locked in a tough game of numbers.
Jan 8- Breast implant maker Sientra Inc said its medical implants were found to be safe during a third-party testing, three months after it suspended sales of the devices to ensure technical compliance. In a letter to plastic surgeons dated Thursday, Chief Executive Jeffrey Nugent said the regulatory bodies had reviewed the device and found it to be safe and...
The recent criticism surrounding $9 billion diagnostics firm Theranos has been unfair, Theranos board member Richard Kovacevich tells CNBC.
Over the past several years, the FDA has received thousands of reports of complications, including bleeding, organ perforation and urinary problems, involving the use of mesh for transvaginal POP repair, the agency said. The FDA noted that an advisory panel of experts in 2011 recommended that more data was needed to establish their safety.